A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2001
12/20/2001	WO2001095920A1 Composition comprising clinoptolite, plant extracts and vitamin b complex for diabetic neuropathy
12/20/2001	WO2001095916A2 Anticholestatic medicament containing luteolin-7-o-glucuronide
12/20/2001	WO2001095906A1 Treatment and prevention of cardiac insulin resistance associated conditions
12/20/2001	WO2001095893A1 Use of an epoxy-steroidal aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
12/20/2001	WO2001095892A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
12/20/2001	WO2001095890A2 Oral pharmaceutical compositions containing terbinafine
12/20/2001	WO2001095859A2 Novel heterocyclic analogs of diphenylethylene compounds
12/20/2001	WO2001095708A1 Vitamin d receptor-deficient cell line
12/20/2001	WO2001066550A3 Compounds for pdt
12/20/2001	WO2001059128A3 Novel elongase gene and method for producing multiple-unsaturated fatty acids
12/20/2001	WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors
12/20/2001	WO2001044295A3 Agonists and antagonists of the receptor gpr19 and their use in appetite control
12/20/2001	WO2001019770A3 Rxr modulators with improved pharmacologic profile
12/20/2001	WO2001015693A3 Treatment of migraine by the administration of alpha-lipoic acid or derivatives thereof
12/20/2001	WO2000072832A3 Novel use of 1-[4-(cyanoindol-3yl)butyl]-4-(carbamoyl-benzofuran-5yl)-piperazine and its physiologically acceptable salts
12/20/2001	WO1999063976A3 Liver-selective glucocorticoid antagonist for treating diabetes
12/20/2001	WO1997049394A3 Sold oral dosage forms of valsartan
12/20/2001	US20010053851 Antidiabetic agents
12/20/2001	US20010053799 New treatments using venlafaxine
12/20/2001	US20010053791 Glycogen phosphorylase inhibitor
12/20/2001	US20010053788 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity
12/20/2001	US20010053782 Pyrrolo[2,3-d]pyrimidine compounds
12/20/2001	US20010053778 Pharmaceutical compositions of glycogen phosphorylase inhibitors
12/20/2001	US20010053763 Method and composition for modulating an immune response
12/20/2001	US20010053761 Method for administering aspb28-human insulin
12/20/2001	US20010053368 Proteosome influenza vaccine
12/20/2001	US20010053363 Novel amphipathic aldehydes and their uses as adjuvants and immunoeffectors
12/20/2001	US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct.
12/20/2001	US20010053351 Inhibition of GSK-3 beta
12/20/2001	DE10029201A1 Retarded release oral dosage form, obtained by granulating mixture containing active agent and polyvinyl acetate-polyvinyl pyrrolidone mixture below the melting temperature
12/20/2001	DE10029047A1 Treating or preventing intrahepatic cholestasis and regulating cholesterol formation, using luteolin-7-O-glucuronide to combat intrahepatic changes in the bile ducts
12/20/2001	CA2719176A1 2-cyanopyrrolidine derivatives and their use as medicaments
12/20/2001	CA2436116A1 Treatment and prevention of cardiac insulin resistance associated conditions
12/20/2001	CA2412979A1 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
12/20/2001	CA2412843A1 Composition comprising clinoptolite, plant extracts and vitamin b complex for diabetic neuropathy
12/20/2001	CA2412632A1 Hmg-coa reductase inhibitors and method
12/20/2001	CA2412216A1 Lactam inhibitors of factor xa and method
12/20/2001	CA2411962A1 Methods for regulating a cell-mediated immune response by blockinglymphocytic signals and by blocking lfa-1 mediated adhesion
12/20/2001	CA2411472A1 Cd154 variants
12/20/2001	CA2410610A1 Human kinases
12/20/2001	CA2410171A1 Novel heterocyclic analogs of diphenylethylene compounds and uses thereof
12/20/2001	CA2409315A1 Protein phosphatases
12/20/2001	CA2407699A1 Use of an aldosterone antagonist for the treatment or prophylaxis of aldosterone-mediated pathogenic effects
12/20/2001	CA2396871A1 Immunostimulatory nucleic acids for inducing a th2 immune response
12/19/2001	EP1163528A2 Prediction of diabetes impaired wound healing
12/19/2001	EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
12/19/2001	EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION
12/19/2001	EP1163332A1 48 human secreted proteins
12/19/2001	EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
12/19/2001	EP1163262A1 Phenylalanine derivatives
12/19/2001	EP1163255A1 50 human secreted proteins
12/19/2001	EP1163239A1 Modified amino-acid amides as cgrp antagonists
12/19/2001	EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001	EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents
12/19/2001	EP1163233A1 Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
12/19/2001	EP1163225A1 Compounds and methods for modulation of estrogen receptors
12/19/2001	EP1163224A1 N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
12/19/2001	EP1163220A1 Tricyclic indole-2-carboxylic acid compound used as nmda receptor antagonist
12/19/2001	EP1163218A1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
12/19/2001	EP1163217A1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
12/19/2001	EP1163214A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
12/19/2001	EP1163208A2 Caspase inhibitors and uses thereof
12/19/2001	EP1163203A1 Crystalline hydrated dihydroxy open-acid simvastatin calcium salt
12/19/2001	EP1162995A2 Medicament for treating diabetes
12/19/2001	EP1162988A1 Wafer delivery system
12/19/2001	EP1162979A2 Cyclic glycerophosphates and analogs thereof
12/19/2001	EP1162966A1 Weight loss after pregnancy
12/19/2001	EP1162965A1 Method of controlling weight gain associated with therapeutic drugs
12/19/2001	EP1162959A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
12/19/2001	EP1162954A1 Novel formulations comprising lipid-regulating agents
12/19/2001	EP1162890A1 A method of preventing parturient hypocalcemia in animals and compositions used therein
12/19/2001	EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001	EP0980349B1 Process for producing conjugated linolenic acid-based synthetic triglycerides
12/19/2001	EP0859778B1 TETRAHYDROIMIDAZOPYRIDOINDOLEDIONES AS INHIBITORS OF cGMP SPECIFIC PDE
12/19/2001	EP0854681B1 Therapeutic diet for dogs with lymphoma
12/19/2001	EP0785794B1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity
12/19/2001	EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation
12/19/2001	CN1327447A 新药物 New Drug
12/19/2001	CN1327446A New medicine
12/19/2001	CN1327389A Coupling factor 6 inhibitor and potentiator and use thereof
12/19/2001	CN1326928A Biphenyl sulfonyl amino-cyanogen, its preparing method and use as medicine thereof
12/19/2001	CN1326782A About human digestive enzyme recombined protein and its preparing method
12/19/2001	CN1326776A Rhodiola root medicinal tea
12/19/2001	CN1326771A Medicine for curing diabetes
12/19/2001	CN1326764A Medicine for lowering blood fat
12/19/2001	CN1326761A Medicinal drink and its producing method
12/19/2001	CN1326754A Aloe and ant capsule
12/19/2001	CN1326752A Medicine for curing apocrine sweat gland hircus
12/19/2001	CN1326747A Protein iron microelement complement agent and its producing method
12/19/2001	CN1076343C Creatine pyruvates and method for their production
12/19/2001	CN1076198C Use of shoot of Mao bamboo in preparation of Chinese medicine for regulating blood lipoid
12/19/2001	CN1076196C Pharmaceutical composition
12/19/2001	CN1076183C 新的饮料 New beverage
12/18/2001	US6331633 Antidiabetic agents with no liver toxicity
12/18/2001	US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand)
12/18/2001	US6331571 Methods of treating and preventing attention deficit disorders
12/18/2001	US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors
12/18/2001	US6331552 Therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorders
12/18/2001	US6331546 Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions
12/18/2001	US6331433 Human T cell leukemia cell line designated D1.1

1 ... 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 ... 1298